Literature DB >> 29242204

SETD2: a complex role in blood malignancy.

Jonathan D Licht1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29242204      PMCID： PMC5731090          DOI： 10.1182/blood-2017-10-811927

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Intragenic DNA methylation prevents spurious transcription initiation.

Authors:  Francesco Neri; Stefania Rapelli; Anna Krepelova; Danny Incarnato; Caterina Parlato; Giulia Basile; Mara Maldotti; Francesca Anselmi; Salvatore Oliviero
Journal:  Nature       Date:  2017-02-22       Impact factor: 49.962

2.  The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSα.

Authors:  Feng Li; Guogen Mao; Dan Tong; Jian Huang; Liya Gu; Wei Yang; Guo-Min Li
Journal:  Cell       Date:  2013-04-25       Impact factor: 41.582

3.  Identification of functional cooperative mutations of SETD2 in human acute leukemia.

Authors:  Xiaofan Zhu; Fuhong He; Huimin Zeng; Shaoping Ling; Aili Chen; Yaqin Wang; Xiaomei Yan; Wei Wei; Yakun Pang; Hui Cheng; Chunlan Hua; Yue Zhang; Xuejing Yang; Xin Lu; Lihua Cao; Lingtong Hao; Lili Dong; Wei Zou; Jun Wu; Xia Li; Si Zheng; Jin Yan; Jing Zhou; Lixia Zhang; Shuangli Mi; Xiaojuan Wang; Li Zhang; Yao Zou; Yumei Chen; Zhe Geng; Jianmin Wang; Jianfeng Zhou; Xin Liu; Jianxiang Wang; Weiping Yuan; Gang Huang; Tao Cheng; Qian-Fei Wang
Journal:  Nat Genet       Date:  2014-02-09       Impact factor: 38.330

4.  Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity.

Authors:  Kun Chen; Juan Liu; Shuxun Liu; Meng Xia; Xiaomin Zhang; Dan Han; Yingming Jiang; Chunmei Wang; Xuetao Cao
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

5.  Methylated α-tubulin antibodies recognize a new microtubule modification on mitotic microtubules.

Authors:  In Young Park; Pratim Chowdhury; Durga Nand Tripathi; Reid T Powell; Ruhee Dere; Esteban A Terzo; W Kimryn Rathmell; Cheryl Lyn Walker
Journal:  MAbs       Date:  2016-09-03       Impact factor: 5.857

6.  SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia.

Authors:  Brenton G Mar; S Haihua Chu; Josephine D Kahn; Andrei V Krivtsov; Richard Koche; Cecilia A Castellano; Jacob L Kotlier; Rebecca L Zon; Marie E McConkey; Jonathan Chabon; Ryan Chappell; Peter V Grauman; James J Hsieh; Scott A Armstrong; Benjamin L Ebert
Journal:  Blood       Date:  2017-10-10       Impact factor: 22.113

7.  SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint.

Authors:  Sílvia Carvalho; Alexandra C Vítor; Sreerama C Sridhara; Filipa B Martins; Ana C Raposo; Joana M P Desterro; João Ferreira; Sérgio F de Almeida
Journal:  Elife       Date:  2014-05-06       Impact factor: 8.140

8.  Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.

Authors:  Andrea B Moffitt; Sarah L Ondrejka; Matthew McKinney; Rachel E Rempel; John R Goodlad; Chun Huat Teh; Sirpa Leppa; Susanna Mannisto; Panu E Kovanen; Eric Tse; Rex K H Au-Yeung; Yok-Lam Kwong; Gopesh Srivastava; Javeed Iqbal; Jiayu Yu; Kikkeri Naresh; Diego Villa; Randy D Gascoyne; Jonathan Said; Magdalena B Czader; Amy Chadburn; Kristy L Richards; Deepthi Rajagopalan; Nicholas S Davis; Eileen C Smith; Brooke C Palus; Tiffany J Tzeng; Jane A Healy; Patricia L Lugar; Jyotishka Datta; Cassandra Love; Shawn Levy; David B Dunson; Yuan Zhuang; Eric D Hsi; Sandeep S Dave
Journal:  J Exp Med       Date:  2017-04-19       Impact factor: 14.307

9.  Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks.

Authors:  François Aymard; Beatrix Bugler; Christine K Schmidt; Emmanuelle Guillou; Pierre Caron; Sébastien Briois; Jason S Iacovoni; Virginie Daburon; Kyle M Miller; Stephen P Jackson; Gaëlle Legube
Journal:  Nat Struct Mol Biol       Date:  2014-03-23       Impact factor: 18.361

10.  Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.

Authors:  Sophia X Pfister; Enni Markkanen; Yanyan Jiang; Sovan Sarkar; Mick Woodcock; Giulia Orlando; Ioanna Mavrommati; Chen-Chun Pai; Lykourgos-Panagiotis Zalmas; Neele Drobnitzky; Grigory L Dianov; Clare Verrill; Valentine M Macaulay; Songmin Ying; Nicholas B La Thangue; Vincenzo D'Angiolella; Anderson J Ryan; Timothy C Humphrey
Journal:  Cancer Cell       Date:  2015-11-09       Impact factor: 31.743
  10 in total
  9 in total

1.  Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.

Authors:  Mark Ettel; Lili Zhao; Shula Schechter; Jiaqi Shi
Journal:  Pathology       Date:  2019-05-03       Impact factor: 5.306

2.  The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications.

Authors:  Diana Giannuzzi; Laura Marconato; Antonella Fanelli; Luca Licenziato; Raffaella De Maria; Andrea Rinaldi; Luca Rotta; Nicole Rouquet; Giovanni Birolo; Piero Fariselli; Afua A Mensah; Francesco Bertoni; Luca Aresu
Journal:  Lab Anim (NY)       Date:  2022-06-20       Impact factor: 12.625

3.  Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance.

Authors:  Veronika Vikova; Michel Jourdan; Nicolas Robert; Guilhem Requirand; Stéphanie Boireau; Angélique Bruyer; Laure Vincent; Guillaume Cartron; Bernard Klein; Olivier Elemento; Alboukadel Kassambara; Jérôme Moreaux
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

4.  Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2.

Authors:  Cheryl A London; William P D Hendricks; Heather L Gardner; Karthigayini Sivaprakasam; Natalia Briones; Victoria Zismann; Nieves Perdigones; Kevin Drenner; Salvatore Facista; Ryan Richholt; Winnie Liang; Jessica Aldrich; Jeffrey M Trent; Peter G Shields; Nicholas Robinson; Jeremy Johnson; Susan Lana; Peter Houghton; Joelle Fenger; Gwendolen Lorch; Katherine A Janeway
Journal:  Commun Biol       Date:  2019-07-19

Review 5.  H3K36me3, message from chromatin to DNA damage repair.

Authors:  Zhongxing Sun; Yanjun Zhang; Junqi Jia; Yuan Fang; Yin Tang; Hongfei Wu; Dong Fang
Journal:  Cell Biosci       Date:  2020-01-31       Impact factor: 7.133

Review 6.  Where We Stand With Precision Therapeutics in Myeloma: Prosperity, Promises, and Pipedreams.

Authors:  Darren Pan; Joshua Richter
Journal:  Front Oncol       Date:  2022-01-20       Impact factor: 6.244

7.  Methyltransferase SETD2 inhibits tumor growth and metastasis via STAT1-IL-8 signaling-mediated epithelial-mesenchymal transition in lung adenocarcinoma.

Authors:  Xin Yang; Rui Chen; Yan Chen; You Zhou; Chen Wu; Qing Li; Jun Wu; Wen-Wei Hu; Wei-Qing Zhao; Wei Wei; Jun-Tao Shi; Mei Ji
Journal:  Cancer Sci       Date:  2022-02-22       Impact factor: 6.716

8.  SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.

Authors:  Bing-Yi Chen; Junhong Song; Cheng-Long Hu; Shu-Bei Chen; Qunling Zhang; Chun-Hui Xu; Ji-Chuan Wu; Dan Hou; Ming Sun; Yuan-Liang Zhang; Na Liu; Peng-Cheng Yu; Ping Liu; Li-Juan Zong; Jia-Ying Zhang; Ruo-Fei Dai; Fei Lan; Qiu-Hua Huang; Su-Jiang Zhang; Stephen D Nimer; Zhu Chen; Sai-Juan Chen; Xiao-Jian Sun; Lan Wang
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

9.  Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials.

Authors:  Lasse S Kristensen; Kirsten Grønbæk; Mette Dahl; Simon Husby; Christian W Eskelund; Søren Besenbacher; Søren Fjelstrup; Christophe Côme; Sara Ek; Arne Kolstad; Riikka Räty; Mats Jerkeman; Christian H Geisler; Jørgen Kjems
Journal:  Leukemia       Date:  2021-07-09       Impact factor: 11.528
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.